Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Company News
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Events
Directory
Search
Close search
Subscribe
Login
Password
Password
Remember me
Forgot password?
Close login form
Home
Actylis – The Partner of Choice
Actylis – The Partner of Choice
Activities:
Manufacturing
Ingredients
Research & Development
Trending Articles
NHS, MHRA and Medicines UK launch Project Revive to tackle medicine shortages
NHS England, the MHRA and Medicines UK have launched Project Revive, a collaborative pilot designed to address critical medicines shortages by fast-tracking dormant...
Isopod Rapid Cleanrooms: the ideal elite controlled environment pod solution for Life Sciences and Engineering start-ups
The Guardtech Group’s quick-assembly cleanroom pods combine superior performance, build quality and cost-effectiveness to give new applications the perfect platform to get...
You need to be a subscriber to read this article.
Click here
to find out more.
Delivering precision: why advanced therapies are redefining pharmaceutical logistics
As advanced therapies narrow tolerances and personalise care, pharmaceutical logistics is being redefined as a precision-driven extension of treatment delivery, writes Michael...
Nose-to-brain delivery outperforms systemic BBB technologies according to MetP Pharma
The pioneering company has published preclinical data that strongly supports the advantages of its proprietary nose-to-brain drug delivery technology compared with systemic...
AstraZeneca strengthens weight management pipeline with CSPC Pharmaceuticals collaboration
The pair have signed a strategic collaboration covering eight obesity and type 2 diabetes programmes, including a clinical-ready GLP-1/GIP asset, AI-driven peptide discovery...
Upcoming event
High Shear = Mixing Success
19 February 2026 | Virtual
See all
Related Content
Manufacturing
Actylis expands into VMS & Pharma with the acquisition of Pharm-Rx
The acquisition strengthens Actylis’ presence in the VMS and OTC markets
Manufacturing
Actylis appoints Scott Thomson as CEO
Scott will endeavour to globally expand the company's integrated manufacturing and sourcing strategy
Distribution
Actylis and Novo Nordisk Pharmatech partner for the distribution of benzalkonium chloride
The two companies aim to expand the distribution of benzalkonium chloride within Europe
Manufacturing
Actylis adds a WFI production system in Canada
The manufacturer of raw materials has launched a Water for Injection (WFI) and additional ISO Class 7 manufacturing in Montreal, Canada
Manufacturing
Actylis opens 30,000 sqft cGMP API facility
The Eugene facility is the latest GMP manufacturing facility that Actylis has commissioned, along with the other GMP sites in Montreal, Limerick and Ahmedabad
Manufacturing
Actylis invests $450k in Manchester facility, UK
The modernisation work was completed during the summer of 2022
Manufacturing
The debut of Actylis signals the creation of a specialty ingredients manufacturing and sourcing powerhouse
The unique hybrid model provides unparalleled flexibility for individualised, customer-centric ingredient solutions along with exceptional supply chain dependability
Subscribe now